Clearance Summary
Southern Transforaminal Lumbar Interbody Fusion (TLIF) received FDA 510(k) clearance under submission number K221182, sponsored by Southern Medical (Pty) , Ltd.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Orthopedic review panel. The statutory decision date of record is 2022-12-08.
- Submission: K221182
- Applicant / Sponsor: Southern Medical (Pty) , Ltd.
- Clearance pathway: Traditional
- Review panel: Orthopedic
- Device class: Class II
- Regulation citation: 21 CFR 888.3080
- Decision date: 2022-12-08
Classification & Regulation
This clearance is catalogued under FDA product code MAX and 21 CFR 888.3080, within the Orthopedic review panel as a Class II device.